These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 1788785)
1. [The results of the combined chemoradiation treatment of lymphosarcomas corresponding to the degree of its intensity]. Kruglova GV; Finogenova IA; Shramko AF Ter Arkh; 1991; 63(7):105-9. PubMed ID: 1788785 [TBL] [Abstract][Full Text] [Related]
2. [Chemoradiation treatment of patients with aggressive non-Hodgkin's lymphomas in stages I to II of the disease]. Sotnikov VM; Polianskaia AM; Pan'shin GA; Ingberman IaKh; Kaplanskaia IB Ter Arkh; 1989; 61(7):20-3. PubMed ID: 2588136 [TBL] [Abstract][Full Text] [Related]
4. [The combined chemoradiotherapy of lymphosarcomas]. Kruglova GV; Finogenova IA Ter Arkh; 1995; 67(10):60-3. PubMed ID: 8779110 [No Abstract] [Full Text] [Related]
5. [The chemoradiation treatment of patients with aggressive non-Hodgkin's lymphomas in the III-IV stages of the disease]. Sotnikov VM; Pan'shin GA; Pivnik AV; Grigor'eva MA Ter Arkh; 1992; 64(7):54-6. PubMed ID: 1440370 [No Abstract] [Full Text] [Related]
6. [Therapy against relapse in generalized lymphoblastic and immunoblastic lymphosarcomas in complete remission]. Mustiatsé LZ; Korchmaru IF Ter Arkh; 1986; 58(6):110-2. PubMed ID: 3764703 [TBL] [Abstract][Full Text] [Related]
7. [A comparative study of ABEP and ACOPE in the treatment of non-Hodgkin's lymphoma CS IV]. Yoshida T; Nakamura S; Ohtake S; Itoh K; Kobayashi K; Hirai J; Kanno M; Matsuda T; Naito K; Nakamura E Rinsho Ketsueki; 1988 Sep; 29(9):1383-7. PubMed ID: 3216509 [No Abstract] [Full Text] [Related]
8. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma. Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737 [TBL] [Abstract][Full Text] [Related]
10. [Treatment by the CHOP protocol in malignant non-Hodgkin lymphomas with high malignancy]. Gociu M; Leahu S; Stoica I; Iofciulescu A; Berceanu S Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(1):47-51. PubMed ID: 2899347 [No Abstract] [Full Text] [Related]
11. [Treatment of malignant lymphoma: 12 years' experience with 109 patients. 2). Treatment of non-Hodgkin's lymphoma]. Furukawa Y; Takagi S; Tsuboyama A; Tsunoda S; Akashi M; Komatsu N; Takeda K; Muroi K; Akutsu M; Ohsaka A Rinsho Ketsueki; 1987 Sep; 28(9):1544-52. PubMed ID: 3437516 [No Abstract] [Full Text] [Related]
12. Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas. (Hellenic co-Operative Oncology Group). Economopoulos T; Fountzilas G; Kostourou A; Daniilidis J; Pavlidis N; Andreopoulou H; Nicolaou A; Papageorgiou E; Mellou S; Dervenoulas J; Stathakis N Anticancer Res; 1998; 18(6B):4655-60. PubMed ID: 9891536 [TBL] [Abstract][Full Text] [Related]
13. [Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, prednisolone (VEPA) in non-Hodgkin's lymphoma, with special reference to correlation of surface phenotype with response and survival]. Chubachi A; Miura AB; Yamaguchi A; Nishimura S Gan To Kagaku Ryoho; 1988 Jul; 15(7):2057-63. PubMed ID: 3293535 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutic results in 22 cases of childhood non-Hodgkin's lymphoma treated by ACOP combination chemotherapy]. Imashuku S; Arakawa S; Todo S; Esumi N; Shimizu Y; Fujiwara F; Tsunamoto K; Morioka Y; Sugimoto T; Fushiki S Gan To Kagaku Ryoho; 1987 Apr; 14(4):1086-93. PubMed ID: 3566305 [TBL] [Abstract][Full Text] [Related]
15. [C-MOPP therapy in advanced diffuse lymphoma, large cell type (LSG)]. Ino T; Okamoto M; Shinkai K; Kojima H; Maruyama F; Sobue R; Ito N; Imura H; Takada T; Morikawa K Rinsho Ketsueki; 1987 Jun; 28(6):839-44. PubMed ID: 3669323 [No Abstract] [Full Text] [Related]
16. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma. Mounier N; Gisselbrecht C; Lepage E N Engl J Med; 1998 Nov; 339(20):1476; author reply 1477. PubMed ID: 9841320 [No Abstract] [Full Text] [Related]
17. [The grouping of morphological variants of non-Hodgkin's lymphomas (lymphosarcomas) by the degree of malignancy]. Sotnikov VM; Kharchenko VP; Pan'shin GA; Galil-Ogly GA; Zakharova LV; Teĭblium MM Klin Med (Mosk); 1996; 74(2):41-3. PubMed ID: 8772102 [TBL] [Abstract][Full Text] [Related]
18. The treatment of non-Hodgkin's lymphoma with mitoxantrone-containing regimens. Sonneveld P Semin Oncol; 1995 Feb; 22(1 Suppl 1):29-31. PubMed ID: 7863349 [No Abstract] [Full Text] [Related]
19. [Results of treating patients with highly malignant non-Hodgkin's lymphomas; comparison of treatment efficacy with CHOP and CBVPM-AVBP]. Urasiński I; Zdziarska B; Wichert K; Zuk E Pol Merkur Lekarski; 1998 Mar; 4(21):137-9. PubMed ID: 9640064 [TBL] [Abstract][Full Text] [Related]
20. Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma. Burton C; Smith P; Vaughan-Hudson G; Qian W; Hoskin P; Cunningham D; Hancock B; Linch D Br J Haematol; 2005 Aug; 130(4):536-41. PubMed ID: 16098067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]